Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I Study of PDR001 in Patients With Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.
- Status
- COMPLETED
- Phase
- PHASE4
Serelaxin To Lower Portal Pressure
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy.
- Status
- TERMINATED
- Phase
- PHASE2
Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event
- Status
- COMPLETED
- Phase
- PHASE4
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Rainbow Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Innate Immune Response in COPD
- Status
- COMPLETED
- Phase
- N/A
QVA Mechanistic Efficacy Study (Receptor Effects, Etc)
- Status
- COMPLETED
- Phase
- PHASE4